Les Hauts D Anjou

Low back pain is a common condition affecting about 23% of the general population and can lead to challenges such as psychosocial difficulties and prolonged inability to work. In France, treatment usually involves general practitioners and sometimes physiotherapists. Researchers are evaluating whether coordinated care involving general practitioners, physiotherapists, and occupational health services can improve the management and outcomes for patients with subacute or recurrent acute low back pain compared to standard care. The study compares two approaches: coordinated care and standard care. Coordinated care includes early contact with occupational health services initiated by the general practitioner and the use of an occupational retention tool. Patients in this group also receive an active physiotherapy program consisting of 15 individual, intensive, and regular rehabilitation sessions lasting one hour each, scheduled two to three times per week. This approach is deployed at the territory level to assess its impact on patient outcomes. Participants will be followed for one year after enrollment. During this time, researchers will monitor the perceived inability to work as the primary outcome. The study involves regular assessments and tracking of patient progress to evaluate the effectiveness of coordinated care in reducing prolonged disability related to low back pain. Overall, the study aims to improve the care pathway and reduce the risk of long-term disability for patients in primary care settings.

Researchers are evaluating the safety and performance of a decongestant seawater spray pocket valve enriched with essential oils by Gilbert Laboratories. This device is intended for patients aged 12 years and older with acute rhinitis associated with nasal obstruction during infectious episodes like rhinopharyngitis or rhinosinusitis, as well as non-infectious episodes such as allergic rhinitis. The study focuses on assessing results over an 8-day period to understand the spray's effects on nasal obstruction symptoms. The study includes measurement of peak nasal flow before and after the first use of the spray on Day 0, and again on Day 3 for one group of participants. The investigation is designed to monitor the performance of the spray pocket valve and its safety in relieving nasal obstruction due to acute rhinitis. Participants will use the spray as directed, and their nasal airflow will be assessed to evaluate the device's impact. Participants will be monitored throughout the 8-day study period, including completing questionnaires and using the spray according to study instructions. Researchers will measure outcomes such as peak nasal flow from Day 0 to Day 3 to evaluate the device's performance. Safety will also be assessed during this time. The study requires participants to be able to use the spray, complete questionnaires, and attend study visits for evaluations.